...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Evaluation of Four Rapid Immunochromatographic Tests for the Detection of Cardiac Troponin I
【24h】

Evaluation of Four Rapid Immunochromatographic Tests for the Detection of Cardiac Troponin I

机译:评估四种快速免疫色谱检测心肌肌钙蛋白I的方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cardiac troponin I (cTnI) is a sensitive and specific marker of acute coronary syndromes and myocardial damage. During the past few years, it has become the preferred biochemical marker of myocardial infarction. However, due to the sensitivity required for its detection, only automated systems can be used in developed countries. However, these are rather expensive and unaffordable for most laboratories in developing countries. Many manufacturers have therefore proposed rapid immunochromatographic tests to detect cTnI. The aim of this study was to assess the limit of detection (LOD) and performance of four rapid immunochromatographic tests available in Madagascar. The four tests evaluated were Hexagon Troponin, Nadal troponin I cassette, Troponitest+, and Amicheck-Trop. Amicheck-Trop had a sensitivity and negative predictive value of about 80%, whereas for the three others, they were about 20%. The specificity of Amicheck-Trop of 87.3% was lower than the specificities of the other tests (98% to 100%). These differences were explained by the limits of detection of the tests: 0.3 to 0.4 ng/ml for Amicheck-Trop but only 1.8 to 2 ng/ml for the three other tests. It was concluded that Amicheck-Trop could be useful in the management of acute myocardial infarction or myocarditis in sparsely equipped laboratories in developing countries.
机译:心肌肌钙蛋白I(cTnI)是急性冠状动脉综合征和心肌损伤的敏感和特异性标志物。在过去的几年中,它已成为心肌梗塞的首选生化指标。但是,由于其检测所需的灵敏度,在发达国家只能使用自动系统。但是,对于发展中国家的大多数实验室而言,这些工具相当昂贵且负担不起。因此,许多制造商提出了快速免疫色谱测试来检测cTnI。这项研究的目的是评估在马达加斯加可用的四种快速免疫色谱检测的检测限(LOD)和性能。评估的四个测试是六角肌钙蛋白,纳达尔肌钙蛋白I盒,Troponitest +和Amicheck-Trop。 Amicheck-Trop的敏感性和阴性预测值约为80%,而其他三个则约为20%。 Amicheck-Trop的特异性为87.3%,低于其他测试的特异性(98%至100%)。这些差异由测试的检测限解释:Amicheck-Trop为0.3到0.4 ng / ml,而其他三个测试仅为1.8到2 ng / ml。结论是,Amicheck-Trop可能在发展中国家的设备稀疏实验室中对急性心肌梗塞或心肌炎的治疗有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号